
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $267.8M | -- | -- | -- | -- |
08/29/2025 | Q2 | $268.8M | -- | -- | -- | -- |
05/14/2025 | Q1 | $152.9M | $144.9M | -$0.27 | -- | -- |
03/06/2025 | Q4 | -- | $92.8M | $0.07 | -- | -- |
11/04/2024 | Q3 | -- | $3.8M | $0.08 | -- | -- |
08/29/2024 | Q2 | -- | $6.3M | $0.11 | -- | -- |
06/12/2024 | Q1 | -- | $9M | $0.11 | -- | -- |
03/11/2024 | Q4 | -- | $18.1M | -$0.13 | -- | -- |
11/27/2023 | Q3 | -- | -- | -$0.06 | -- | -- |
08/23/2023 | Q2 | -- | -- | $0.04 | -- | -- |
06/08/2023 | Q1 | -- | -- | $0.08 | -- | -- |
03/09/2023 | Q4 | -- | -- | -$0.58 | -$0.11 | -$0.47 |
11/29/2022 | Q3 | -- | -- | -$0.14 | -$0.21 | $0.07 |
08/29/2022 | Q2 | -- | -- | -$0.31 | -$0.16 | -$0.16 |
06/09/2022 | Q1 | -- | -- | -$0.15 | -- | -- |
03/10/2022 | Q4 | -- | -- | $0.14 | $0.21 | -$0.07 |
11/22/2021 | Q3 | -- | -- | -$0.45 | $0.05 | -$0.50 |
08/19/2021 | Q2 | -- | -- | $1.16 | $0.25 | $0.91 |
05/31/2021 | Q1 | -- | -- | -$0.57 | $0.10 | -$0.66 |
03/11/2021 | Q4 | -- | -- | $3.14 | $1.41 | $1.73 |
11/23/2020 | Q3 | -- | -- | $1.70 | $0.07 | $1.63 |
08/24/2020 | Q2 | -- | -- | $0.13 | $0.05 | $0.09 |
05/27/2020 | Q1 | -- | -- | -$0.07 | -$0.01 | -$0.06 |
03/23/2020 | Q4 | -- | -- | $0.18 | $0.09 | $0.09 |
11/14/2019 | Q3 | -- | -- | $0.11 | $0.08 | $0.03 |
09/03/2019 | Q2 | -- | -- | $0.18 | $0.09 | $0.09 |
05/28/2019 | Q1 | -- | -- | $0.15 | $0.09 | $0.06 |
03/27/2019 | Q4 | -- | -- | $0.05 | $0.19 | -$0.14 |
11/22/2018 | Q3 | -- | -- | $0.11 | -- | -- |
08/30/2018 | Q2 | -- | -- | $0.06 | -- | -- |
03/31/2018 | Q1 | -- | -- | $0.09 | -- | -- |
12/31/2017 | Q4 | -- | -- | $0.04 | -- | -- |
09/30/2017 | Q3 | -- | -- | $0.13 | -- | -- |
06/30/2017 | Q2 | -- | -- | $0.11 | -- | -- |
03/31/2017 | Q1 | -- | -- | $0.07 | -- | -- |
Cango reported $144.9M worth of top line sales in its most recent quarter.
Cango announced earnings per share of -$0.27 which represents a miss of analyst forecast a -- per share.
Cango reported $13.6M that represents $0.13 per share over the last quarter.
Cango's earnings are forecast to grow from $0.36 per share to -- per share next year representing an increase of --.
Cango's next earnings date is August 29, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.